Randomized Clinical Trial to Evaluate the Predictive Accuracy of a Gene Expression for Stage I-II Breast Cancer

NCT00336791 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

273

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: 5-Fluorouracil
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Paclitaxel
DRUG: Epirubicin

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]